COVID-19 infection and high intracoronary thrombus burden

dc.creatorKirresh, Ali
dc.creatorCoghlan, Gerry
dc.creatorCandilio, Luciano
dc.date.accessioned2020-09-01T16:03:53Z
dc.date.accessioned2022-09-23T18:02:57Z
dc.date.available2020-09-01T16:03:53Z
dc.date.available2022-09-23T18:02:57Z
dc.date.created2020-09-01T16:03:53Z
dc.identifier1553-8389
dc.identifierhttps://doi.org/10.1016/j.carrev.2020.07.032
dc.identifierhttp://hdl.handle.net/20.500.12010/12547
dc.identifierhttps://doi.org/10.1016/j.carrev.2020.07.032
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3493922
dc.description.abstractCoronavirus 2019 (COVID-19) is an acute respiratory disease that has rapidly spread around the world and been declared a global pandemic by the World Health Organization. Emerging evidence demonstrates a strong association with a prothrombotic state and we present the first patient admitted with COVID-19 and an inferior ST-segment elevation myocardial infarction (STEMI) with evidence of high intracoronary thrombus burden. We review the mechanism of the high thrombus burden, which may be driven by the significant cytokine storm, endothelial dysfunction, increase risk of coronary plaque rupture and hypercoagulability.
dc.languageeng
dc.publisherCardiovascular Revascularization Medicine
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAcceso restringido
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.subjectMyocardial infartion
dc.subjectCoronary thrombus
dc.titleCOVID-19 infection and high intracoronary thrombus burden


Este ítem pertenece a la siguiente institución